Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (52 quarters reported)
$141M in Q4 2013 → $175M now. Hover for any quarter.
As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| SS SPDR Series Trust | 16.2% | Added 20% | 180,000 | $28.4M |
| Humana Inc | 3.9% | Trimmed 12% | 17,700 | $6.75M |
| Johnson & Johnson | 3.6% | Added 20% | 24,000 | $6.35M |
| Merck & Co Inc | 3.3% | Unchanged | 40,000 | $5.81M |
| Abbvie Inc | 3.3% | Added 47% | 22,000 | $5.75M |
| Thermo Fisher Scientific Inc | 3.3% | Added 6.3% | 8,500 | $5.74M |
| Cardinal Health Inc | 3.2% | Added 4.2% | 25,000 | $5.56M |
| Mckesson Corp | 3.2% | Added 63% | 6,500 | $5.55M |
| DD Danaher Corp Del | 3.2% | Added 25% | 25,000 | $5.54M |
| Unitedhealth Group Inc | 3.1% | Added 50% | 15,000 | $5.51M |
| Vertex Pharmaceuticals Inc | 3.1% | Added 5.0% | 10,500 | $5.49M |
| Elevance Health Inc | 3.1% | Added 180% | 14,000 | $5.44M |
| Abbott Laboratories | 3.1% | Added 120% | 55,000 | $5.44M |
| Cencora Inc | 3.1% | Added 20% | 18,000 | $5.4M |
| Agilent Technologies Inc | 3.0% | Unchanged | 30,000 | $5.17M |
| CD Centene Corp Del | 2.8% | New | 80,000 | $4.97M |
| EL Eli Lilly & Co | 2.8% | Trimmed 15% | 4,230 | $4.89M |
| Encompass Health Corp | 2.8% | Added 167% | 40,000 | $4.86M |
| Revvity Inc | 2.6% | New | 30,000 | $4.59M |
| Waters Corp | 2.5% | Trimmed 33% | 10,000 | $4.39M |
| Bruker Corp | 2.4% | New | 65,000 | $4.21M |
| Edwards Lifesciences Corp | 2.2% | Added 125% | 45,000 | $3.88M |
| Medtronic PLC | 2.2% | New | 45,000 | $3.88M |
| Repligen Corp | 2.2% | New | 20,000 | $3.84M |
| Mettler Toledo International | 2.2% | Trimmed 9.1% | 2,500 | $3.78M |
| Gilead Sciences Inc | 2.1% | Unchanged | 25,000 | $3.73M |
| The Cigna Group | 2.1% | New | 13,203 | $3.59M |
| Biogen Inc | 1.9% | Unchanged | 15,000 | $3.39M |
| BR Bio Rad Labs Inc | 1.7% | Trimmed 20% | 8,000 | $3.02M |
| Avantor Inc | 1.5% | New | 175,000 | $2.63M |
| Biontech Se | 1.2% | New | 22,000 | $2.16M |
| Moderna Inc | 1.1% | New | 10,000 | $1.93M |
| Argenx Se | 1.1% | New | 2,000 | $1.92M |
| Madrigal Pharmaceuticals Inc | 0.7% | New | 2,500 | $1.26M |
| Twist Bioscience Corp | 0.1% | New | 1,128 | $218K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2026 · filed October 13, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CB Call- Bsx 100 @ 75 Exp 04/17/2026 | Exited | −800 | −$5.02M | — |
| CD Centene Corp Del | New | +80,000 | +$4.97M | 2.8% |
| SS SPDR Series Trust | Added | +30,000 | +$4.73M | 16.2% |
| Revvity Inc | New | +30,000 | +$4.59M | 2.6% |
| Bruker Corp | New | +65,000 | +$4.21M | 2.4% |
| IS Intuitive Surg | Exited | −9,000 | −$4.15M | — |
| Astrazeneca PLC | Exited | −20,000 | −$3.94M | — |
| Boston Scientific Corporation | Exited | −62,000 | −$3.89M | — |
| Medtronic PLC | New | +45,000 | +$3.88M | 2.2% |
| Repligen Corp | New | +20,000 | +$3.84M | 2.2% |
Showing the 10 largest of 42 changes.
quarter ended June 30, 2026 · filed July 20, 2026
No position changes this quarter.
quarter ended March 31, 2026 · filed April 15, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| P- Put - Spy 100 @ 684 Exp 01/30/2026 | Exited | −300 | −$20.5M | — |
| P- Put - Spy 100 @ 680 Exp 02/20/2026 | Exited | −250 | −$17M | — |
| P- Put - Spy 100 @ 688 Exp 01/30/2026 | Exited | −250 | −$17M | — |
| P- Put - Spy 100 @ 679 Exp 01/30/2026 | Exited | −250 | −$17M | — |
| P- Put - Spy 100 @ 682 Exp 01/30/2026 | Exited | −250 | −$17M | — |
| P- Put - Spy 100 @ 681 Exp 01/30/2026 | Exited | −250 | −$17M | — |
| P- Put - Spy 100 @ 683 Exp 01/30/2026 | Exited | −250 | −$17M | — |
| P- Put - Spy 100 @ 682 Exp 02/20/2026 | Exited | −250 | −$17M | — |
| SS State Street SPDR S&P Biotech | Trimmed | −75,000 | −$9.58M | 14.5% |
| Hca Healthcare Inc | Exited | −15,000 | −$7M | — |
Showing the 10 largest of 55 changes.
quarter ended December 31, 2025 · filed January 21, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| P- Put - Spy 100 @ 684 Exp 01/30/2026 | New | +300 | +$20.5M | 5.9% |
| P- Put - Spy 100 @ 645 Exp 10/31/2025 | Exited | −300 | −$20M | — |
| P- Put - Spy 100 @ 680 Exp 02/20/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 688 Exp 01/30/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 679 Exp 01/30/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 682 Exp 01/30/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 681 Exp 01/30/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 683 Exp 01/30/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 682 Exp 02/20/2026 | New | +250 | +$17M | 4.9% |
| P- Put - Spy 100 @ 635 Exp 10/31/2025 | Exited | −250 | −$16.7M | — |
Showing the 10 largest of 60 changes.
quarter ended September 30, 2025 · filed October 23, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| P- Put - Spy 100 @ 599 Exp 07/18/2025 | Exited | −400 | −$24M | — |
| P- Put - Spy 100 @ 596 Exp 07/18/2025 | Exited | −400 | −$23.8M | — |
| P- Put - Spy 100 @ 645 Exp 10/31/2025 | New | +300 | +$20M | 5.8% |
| P- Put - Spy 100 @ 602 Exp 07/31/2025 | Exited | −300 | −$18.1M | — |
| P- Put - Spy 100 @ 597 Exp 07/18/2025 | Exited | −300 | −$17.9M | — |
| P- Put - Spy 100 @ 635 Exp 10/31/2025 | New | +250 | +$16.7M | 4.8% |
| P- Put - Spy 100 @ 660 Exp 10/31/2025 | New | +250 | +$16.7M | 4.8% |
| P- Put - Spy 100 @ 655 Exp 10/31/2025 | New | +250 | +$16.7M | 4.8% |
| P- Put - Spy 100 @ 660 Exp 11/21/2025 | New | +250 | +$16.7M | 4.8% |
| P- Put - Spy 100 @ 658 Exp 10/31/2025 | New | +250 | +$16.7M | 4.8% |
Showing the 10 largest of 61 changes.
quarter ended June 30, 2025 · filed July 25, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| P- Put - Spy 100 @ 599 Exp 07/18/2025 | New | +400 | +$24M | 6.5% |
| P- Put - Spy 100 @ 596 Exp 07/18/2025 | New | +400 | +$23.8M | 6.5% |
| P- Put - Spy 100 @ 602 Exp 07/31/2025 | New | +300 | +$18.1M | 4.9% |
| P- Put - Spy 100 @ 597 Exp 07/18/2025 | New | +300 | +$17.9M | 4.9% |
| P- Put - Spy 100 @ 610 Exp 08/15/2025 | New | +250 | +$15.3M | 4.1% |
| P- Put - Spy 100 @ 607 Exp 07/31/2025 | New | +250 | +$15.2M | 4.1% |
| P- Put - Spy 100 @ 600 Exp 08/15/2025 | New | +250 | +$15M | 4.1% |
| P- Put - Spy 100 @ 593 Exp 07/31/2025 | New | +250 | +$14.8M | 4.0% |
| AP Astrazeneca Plc-spons ADR | Exited | −70,000 | −$5.15M | — |
| QD Quest Diagnostic Inc | New | +25,000 | +$4.49M | 1.2% |
Showing the 10 largest of 45 changes.
quarter ended March 31, 2025 · filed April 22, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| IS Intuitive Surg | Exited | −15,000 | −$7.83M | — |
| IS Intuitive Surg | New | +14,000 | +$6.93M | 3.7% |
| Medtronic Inc | New | +75,000 | +$6.74M | 3.6% |
| Baxter International Inc. | New | +175,000 | +$5.99M | 3.2% |
| Vertex Pharmaceuticals Inc. | Exited | −13,000 | −$5.24M | — |
| AP Astrazeneca Plc-spons ADR | New | +70,000 | +$5.15M | 2.8% |
| EL Eli Lilly & Co | Trimmed | −6,000 | −$4.96M | 4.0% |
| Gilead Sciences Inc | New | +40,000 | +$4.48M | 2.4% |
| Abbvie Inc | Exited | −25,000 | −$4.44M | — |
| SS SPDR S&P Biotech ETF | Added | +50,000 | +$4.06M | 11.0% |
Showing the 10 largest of 42 changes.
quarter ended December 31, 2024 · filed January 23, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P Biotech ETF | Trimmed | −100,000 | −$9.01M | 9.5% |
| IS Intuitive Surg | Exited | −17,500 | −$8.6M | — |
| IS Intuitive Surg | New | +15,000 | +$7.83M | 4.1% |
| UG Unitedhealth Grp | New | +12,500 | +$6.32M | 3.3% |
| BD Becton Dickinson Co | Exited | −25,000 | −$6.03M | — |
| Baxter International Inc. | Exited | −150,000 | −$5.7M | — |
| Medtronic Inc | Exited | −60,000 | −$5.4M | — |
| Waters Corp | New | +14,000 | +$5.19M | 2.7% |
| Revvity Inc | Exited | −40,000 | −$5.11M | — |
| West Pharmaceutical Services Inc | Exited | −17,000 | −$5.1M | — |
Showing the 10 largest of 47 changes.
Loading...
